The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness

J Psychopharmacol. 2008 Mar;22(2 Suppl):3-5. doi: 10.1177/0269881107088434.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Humans
  • Hyperprolactinemia / chemically induced*
  • Hyperprolactinemia / complications
  • Mental Disorders / drug therapy*
  • Severity of Illness Index

Substances

  • Antipsychotic Agents